Clinical Trial: Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944457) titled 'Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor' on Nov. 18, 2024.

Brief Summary: A Phase I, Open-label, Single-center, Dose-escalation and Dose-finding Clinical trial to evaluate the safety, tolerability and pharmacokinetics of MPD-1 in patients with advanced solid tumor

Study Start Date: Dec. 10, 2024

Study Type: INTERVENTIONAL

Condition: Cancer Solid Tumor Cancer Biomarkers

Intervention: DRUG: MPD-1

It is a prodrug that uses Doxorubicin to target KRAS mutant/ PTEN loss advanced cancer.

Recruitment Status: RECRUITING

Sponsor: Pharosgen Co.,Ltd

Publi...